With a client base spanning pharmaceutical, medical devices and biotech companies, Mayer Brown offers a full range of contentious and advisory IP services, covering Hatch-Waxman disputes and infringement allegations, while also overseeing cross-border mergers and joint ventures and associated IP strategies. Leading the team out of New York are Lisa Ferri, who frequently appears before the PTAB and Federal Appeals Courts in complex patent trials, while also working alongside Reb Wheeler to oversee transactions in the sector, including M&A, private equity acquisitions and joint ventures.
Legal 500 redaktioneller Kommentar

Kernmandanten

  • Gilead Sciences
  • Roivant Sciences
  • Takeda Pharmaceutical Company Limited
  • Galderma Laboratories, L.P.
  • Sanofi
  • Regeneron
  • GSK
  • Gerber Products Company
  • bioMérieux SA
  • Nestlé Health Science

Anwält*innen

Führende Partner*innen

Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.

Lisa Ferri
Reb Wheeler

Praxisleitung

Lisa Ferri; Reb Wheeler